HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Ferrous Oxalate

HCID 10589
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
516-03-0
Standard SMILES
O=C([O-])C(=O)[O-].[Fe+2]
InChIKey
OWZIYWAUNZMLRT-UHFFFAOYSA-L
Molecular formula
C2FeO4
Average molar mass
143.86 g/mol
Monoisotopic mass
143.914594

Overview

Ferrous oxalate is an odorless yellow solid. Insoluble in water and denser in water. Sinks in water. (USCG, 1999)

Names & identifiers

Preferred name
Ferrous Oxalate
IUPAC
iron(2+);oxalate
English name
Ferrous oxalate
Molecular formula
C2FeO4
Molecular weight
143.86

Names & synonyms

FERROUS OXALATE516-03-0Iron(II) oxalateIron protoxalateIron(2+) oxalateDZP4YV3ICVUNII-DZP4YV3ICVIron oxalate (FeC2O4)EINECS 208-217-4Oxalic acid, iron(2+) salt (1:1)HSDB 463FERROUS OXALATE [MI]
Show more names
IRON OXALATEferrox[qr]Fe2C2O4.2H2Oironoxalate[qr]IRON (II) OXALATEironprotoxalate[qr]iron(ii)oxalate[qr]iron(2+)oxalate[qr]Iron(Ii)Oxalate,Gpr
Ethanedioic acid, iron(2+) salt (1:1)FERROUS OXALATE [HSDB]FERROX (FE(C2O4))FERROUS OXALATE [MART.]FERROUS OXALATE (1:1)FERROUS OXALATE [WHO-DD]Iron, [ethanedioato(2-)-.kappa.O1,.kappa.O2]-FERROUS OXALATE (FE(C2O4))

Database identifiers

CAS
516-03-0、6047-25-2
PubChem CID
10589
DTXSID
DTXSID4060159
UNII
DZP4YV3ICV
EC Number
208-217-4、611-981-5
Nikkaji
J415D

Properties

Computed structural properties

Topological polar surface area
80.3 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
0
Heavy atoms
7
Formal charge
0
Complexity
60.5

Experimental & physicochemical properties

Chemical ClassesMetals -> Metals, Inorganic Compounds
Density · 2 items

2.3 at 68 °F (USCG, 1999) - Denser than water; will sink

Pale yellow crystaline powder. Odorless; decomp AT 150-160 °C on heating in air. Density: 2.28. Slightly soluble in water; soluble in dilute mineral acids. /Dihydrate/

Melting PointMP: DECOMP 190 °C /DIHYDRATE/
Physical Description · 2 items

Ferrous oxalate is an odorless yellow solid. Insoluble in water and denser in water. Sinks in water. (USCG, 1999)

Dihydrate: Pale yellow odorless solid, slightly soluble in water; [Merck Index] Pale yellow odorless crystalline powder; [MSDSonline]

Other Experimental Properties · 3 items

RHOMBIC /DIHYDRATE/

Yellow crystals /Ferrous oxalate dihydrate/

Sugar, glycerin, & many organic hydroxy acids hinder precipitation. In neutral solution, soluble carbonates, phosphates, & oxalates produce precipitation. /Ferrous salts/

Physicochemical properties

Melting point

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 6 items

Warning

H302+H312 (45.1%): Harmful if swallowed or in contact with skin [Warning Acute toxicity, oral; acute toxicity, dermal]

P264, P270, P280, P301+P317, P302+P352, P317, P321, P330, P362+P364, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 82 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Warning

H302+H312 (39%): Harmful if swallowed or in contact with skin [Warning Acute toxicity, oral; acute toxicity, dermal]

Hazard information

Regulatory Information · 4 items

Chemical: Ethanedioic acid, iron(2+) salt (1:1)

Chemical: Iron, diaqua(ethanedioato(2-)-O,O')-

REACH registered substance: Iron(II) oxalate (EC: 208-217-4)

Iron (II) oxalate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety Information · 2 items

Evaluation - Chemicals that are unlikely to require further regulation to manage risks to human health

Evaluation - Chemicals not considered for in depth evaluation - Not commercially active in Australia

Fire HazardsSpecial Hazards of Combustion Products: Iron fume or iron oxide fume may form in fire. (USCG, 1999)
Health Hazards · 1 item

Inhalation of dust may cause irritation of nose and throat. Ingestion causes burning pain in throat and stomach; mucous membranes turn white; can also cause vomiting, weak pulse, collapse, and death. Dust irritates eyes and may irritate skin on prolonged contact. (USCG, 1999)

Chemistry & industry

Pharmacology

Absorption, Distribution and Excretion · 2 items

...Bioavailability of Ferosol-1 /(a ferrous oxalate antianemic powder including copper, zinc, and cobalt) was determined/ by giving it to rabbits with experimental posthemorrhagic anemia. ...Iron from Ferosol-1 was found to be well assimilated and to take place in hemopoetic processes of rabbit. /Ferosol-1/

In hemochromatosis and other disorders associated with iron overload, a significant fraction of the total iron in plasma circulates in the form of low molecular weight complexes not bound to transferrin. Efficient and unregulated clearance of this form of iron by the liver may account for the hepatic iron loading and toxicity that characterize these diseases. ...This possibility /was tested/ by examining the hepatic removal process for representative iron complexes in the single-pass perfused rat liver. Hepatic uptake of both ferrous and ferric 55Fe from ultrafiltered human serum was found to be highly efficient and effectively irreversible (single-pass extraction of 1 microM iron, 58-75%). Similar high efficiencies were seen for iron complexed to specific physiologic and nonphysiologic coordinators, including histidine, citrate, fructose, oxalate and glutamate, and tricine. Because of lower plasma flow rates, single-pass extraction of these iron complexes in vivo should be even greater. Autoradiography confirmed that most iron had been removed by parenchymal cells. Hepatic removal from Krebs-tricine buffer was saturable with similar kinetic parameters for ferrous and ferric iron (apparent Km, 14-22 microM; V max, 24-38 nmol/min/g liver). These findings suggest that high levels of non-transferrin-bound iron in plasma may be an important cause of hepatic iron loading in iron overload states.

Uses & manufacturing

Uses · 5 items

Used as a photographic developer (silver bromide-gelatin plates), glass tint (sunglasses and windshields), decorative glass colorant, and pigment (plastics, paints, and lacquers); [Merck Index]

Painting (Pigments, Binders, and Biocides) [Category: Paint]

Glassblowing [Category: Hobbies]

Photographic developer for silver bromide-gelatin plates; for decorative glassware; to impart a greenish-brown tint to optical glass (sunglasses, windshields, railroad car windows); pigment for plastics, paints, lacquers.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
190 °C · 190°C
Density
2.3 · 2.30
vapor pressure
0.038 Pa · 0.038Pa at 25℃
storage temp.
Inert atmosphere,Room Temperature
solubility
Soluble in acids
form
Powder
Appearance
Light yellow to yellow Solid
Water Solubility
Slightly soluble
Sensitive
Hygroscopic
Exposure limits
1 mg/m3NIOSH: · ACGIH: TWA 1 mg/m3NIOSH: TWA 1 mg/m3
InChI
InChI=1S/C2H2O4.Fe/c3-1(4)2(5)6;/h(H,3,4)(H,5,6);/q;+2/p-2
InChIKey
OWZIYWAUNZMLRT-UHFFFAOYSA-L
SMILES
O=C1O[Fe]OC1=O
LogP
-0.855 · -0.855
CAS DataBase Reference
516 · 516-03-0(CAS DataBase Reference)
FDA UNII
4 YV3ICV · DZP4YV3ICV
EPA Substance Registry System
2 · Iron, [ethanedioato(2-)-.kappa.O1,.kappa.O2]- (516-03-0)
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H312
Precautionary statements
264 · P264-P270-P280h-P301+P312a-P321-P501a
RIDADR
3288 · UN3288
TSCA
TSCA listed
HazardClass
6.1 · 6.1
PackingGroup
III
Hazardous Substances Data
516 · 516-03-0(Hazardous Substances Data)
REACH Registrations
Active
Hazards Summary
An eye, nose, and throat irritant; [CAMEO] An irritant; [MSDSonline] See Iron salts, soluble.
Reactive GroupSalts, Basic
Reactivity ProfileWeak inorganic reducing agents, such as FERROUS OXALATE, react with oxidizing agents to generate heat and products that may be flammable, combustible, or otherwise reactive.
Air and Water ReactionsInsoluble in water.
Hazard Classes and Categories · 2 items

Acute Tox. 4 (100%)

Acute Tox. 4 (100%)

Federal Drinking Water GuidelinesEPA 300 ug/L /Iron/
Skin, Eye, and Respiratory IrritationsIf inhaled, iron is a local irritant to the lung and gastrointestinal tract. /Iron compounds/
Hazardous Reactivities and IncompatibilitiesEvolves carbon monoxide on heating

Safety & protection

First Aid(must be prompt)
Disposal Methods · 1 item

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

Preventive Measures · 3 items

SRP: Local exhaust ventilation should be applied wherever there is an incidence of point source emissions or dispersion of regulated contaminants in the work area. Ventilation control of the contaminant as close to its point of generation is both the most economical and safest method to minimize personnel exposure to airborne contaminants.

SRP: The scientific literature for the use of contact lenses in industry is conflicting. The benefit or detrimental effects of wearing contact lenses depend not only upon the substance, but also on factors including the form of the substance, characteristics and duration of the exposure, the uses of other eye protection equipment, and the hygiene of the lenses. However, there may be individual substances whose irritating or corrosive properties are such that the wearing of contact lenses would be harmful to the eye. In those specific cases, contact lenses should not be worn. In any event, the usual eye protection equipment should be worn even when contact lenses are in place.

All ... /iron/ preparations should be kept in child-proof bottles. /Iron preparations/

Threshold Limit Values (TLV)1.0 [mg/m3], as Fe (soluble iron salts)
Protective Action Criteria (PAC) · 3 items

5.2 [mg/m3]

57 [mg/m3]

340 [mg/m3]

Personal Protective Equipment (PPE)Dust mask; goggles or face shield; protective gloves (USCG, 1999)
Other Standards Regulations and GuidelinesAustralia, Belgium, Finland, Italy, Netherlands, & Switzerland: 1 mg/cu m. /Iron salts/

Toxicology

Adverse EffectsOccupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
Non-Human Toxicity Excerpts · 2 items

/LABORATORY ANIMALS: Acute Exposure/ /Investigators/ ...synthesized ferrous oxalate and prepared a stable antianemic powder Ferosol-1 including copper, zinc and cobalt. ...To estimate a local action of this powder... guinea pigs... were /used/. ...Ferosol-1 is of low toxicity (LD50 = 2.25 g/kg), it does not irritate mucosa of duodenum and ventriculus and could be used orally. ... /Ferosol-1/

/LABORATORY ANIMALS: Acute Exposure/ Experiments with white mice showed low toxicity of Ferosol-2 (LD50 = 4.3 g/kg, for 1 composition and 4.6 g/kg for 2 composition). It does not irritate mucosa of duodenum and ventriculus. /Ferosol-2/

Populations at Special Risk · 1 item

...There is concern that the individual with metabolic defects that impair the ability to regulate iron absorption will be at risk from excessive exposure to iron, primarily as a result of acceleration of accumulation of iron in the body and an earlier onset of clinical symptoms of the disease. /Iron salts/

Antidote and Emergency Treatment · 5 items

Basic treatment: Establish a patent airway. Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations as needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with normal saline during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover chemical bums with dry, sterile dressings after decontamination ... . /Oxalate and Related Compounds/

Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the unconscious patient. Monitor cardiac rhythm and treat arrhythmias as necessary ... . Start an IV with lactated Ringer's /SRP: "To keep open", minimal flow rate/. Watch for signs of fluid overload. For hypotension with signs of hypovolemia, administer fluid cautiously. Watch for signs of fluid overload ... . Treat seizures with diazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Oxalate and Related Compounds/

Maintain an open airway and assist ventilation if necessary. Treat shock caused by hemorrhagic gastrointestinitis aggressively with intravenous crystalloid fluids, and replace blood if needed. Patients are often markedly hypovolemic owing to gastrointestinal losses and third spacing of fluids into the intestinal wall and interstitial space. Treat coma, seizures, and metabolic acidosis if they occur. For seriously intoxicated victims (eg, shock, severe acidosis, and/or serum iron > 500-600 mcg/dL) administer deferoxamine. Monitor the urine for the urine for the characteristic orange or pink deferoxamine-iron complex. Therapy may be stopped when the urine returns to normal or when the serum iron level decreases to the normal range. Prolonged deferoxamine has been associated with adult respiratory distress syndrome and Yersinia sepsis.

Activated charcoal is not effective. Ipecac is not recommended, because it can aggravate iron-induced gastrointestinal irritation and interfere with whole bowel irrigation. Consider gastric lavage if product was a liquid formulation or tablets were chewed. Do-not use phosphate-containing solutions for lavage; these may result in life-threatening hypernatremia, hyperphosphatemia, and hypocalcemia. Bicarbonate and deferoxamine lavage are of doubtful efficacy. Deferoxamine lavage is not effective and may enhance iron absorption. Whole-bowel irrigation is very effective for ingested tablets and may be considered first-line treatment, especially if large numbers of tablets are visible on plain abdominal x-ray. Massive ingestions may lead to concretions or bezoars. Repeated or prolonged whole-bowel irrigation may remove tablets. Endoscopy or surgical gastrotomy is rarely required.

Hemodialysis and hemoperfusion are not effective for removing iron but may be necessary to remove iron-deferoxamine complex in patients with renal failure. Exchange transfusion is occasionally used for massive pediatric ingestions but is of questionable efficacy.

Regulatory information

Federal Drinking Water GuidelinesEPA 300 ug/L /Iron/

Safety data

tsca
TSCA listed
ridadr
UN3288
Signal word
Warning
Symbol(GHS)
GHS07
hazard_class
6.1
packing_group
III
Hazard statements
H302-H312
REACH Registrations
Active
Precautionary statements
P264-P270-P280h-P301+P312a-P321-P501a
Hazardous Substances Data
516-03-0(Hazardous Substances Data)

Catalysts, pigments, drugs, agriculture, nutrition, metallurgy, and leather tanning. /Iron compounds/

Methods of ManufacturingBy the interaction of solutions ferrous sulfate and sodium oxalate.
Formulations/PreparationsFerosol-1: Antianemic powder including copper, zinc, and cobalt. Ferosol-2: antianemic powder including copper, zinc, cobalt, manganese, and calcium (sometimes ascorbic acid also).
General Manufacturing InformationIron, [ethanedioato(2-)-.kappa.O1,.kappa.O2]-: ACTIVE
Applications · 4 items

DescriptionFerrous oxalate, or iron (II) oxalate, is a chemical compound consisting of one iron (II) ion (Fe2+) and one oxalate ion (C2O42-). It has the chemical formula FeC2O4. Iron(II) oxalate is more commonly encountered as the dihydrate, FeC2O4·2H2O . Its crystal structure consists of chains of oxalatebridged iron atoms, capped by water molecules. When heated, it dehydrates and decomposes into carbon dioxide, carbon monoxide, iron oxides and pyrophoric black iron.

UsesUsed as a photographic developer, glass tint, decorative glass colorant, and pigment in plastics, paints, and lacquers.

UsesPhotographic developer, pigment in glass, plastics, paints.

General DescriptionOdorless yellow solid. Insoluble in water and denser in water. Sinks in water.

Upstream & downstream products

Upstream raw materials

WaterCarbon dioxide

Downstream products

Ferrous oxalate dihydrate